Please log in
You must be logged in to send the contact request.
Provide your contact details to the exhibitor. Optionally, you may also add a personal message.
You must be logged in to send the contact request.
Please check your internet connection or try again later.
Your message to the exhibitor was sent successfully.
Diagnostic tests for cancer
Polymerase chain reaction (PCR)
Product category: Diagnostic tests for cancer
Product category: Diagnostic tests for cancer, DNA testing
Product category: Diagnostic tests for cancer
Product category: Diagnostic tests for cancer
Date
Topic
Download
Nov 12, 2020
International distributors, wanted!
Oct 29, 2020
Diagnostic test for the detection of SARS-CoV-2 virus
Sep 29, 2020
Successful validation of EasyPGX PIK3CA testing
PIK3CA mutation testing - quick and easy! That this is possible was shown by our successful participation in the round robin test of PIK3CA (tissue and liquid biopsy) organized by QuiP, the external quality assessment service in Germany.
Due to the recent approval of alpelisib by the European Commission for the treatment of patients with HR +/HER2- advanced breast cancer, it is necessary that the laboratories are able to provide validated tests for PIK3CA mutations, as they will decide whether patients are eligible for treatment with alpelisib or not.EasyPGX® ready PIK3CA is a Real Time PCR-based CE-IVD test for the mutational analysis of the PIK3CA gene.